Skip to content
BMarker
TransactionsPerformanceSharingStocks & ETFsDemoPricingAPI Docs
Open app
Menu
TransactionsPerformanceSharingStocks & ETFsDemoPricingAPI Docs
Open app
  • CME vs GSK✓SelectedUSD · GSKCME vs GSK performance historyLatest closeAs of+0.41%11/20
Stock and ETF performance explorer

CME vs GSK

vs
1w1mo3mo6mo1y3y5y10yallcustom
Portfolio return
+295.6%
GSK return
+97.4%
Excess return
+198.2%
Maximum drawdown
-37.4%

Performance

Returns, benchmark comparison, and relative performance.

Performance by timeframe

Returns for 10y.

Portfolio and benchmark returns by period
PeriodPortfolioGSKExcessAlpha
1D+0.4%-0.1%+0.5%+0.4%
7D-3.3%-5.3%+2.1%-1.6%
30D+4.0%-3.7%+7.6%+5.1%
3M+14.1%-7.3%+21.3%+16.6%
6M+7.1%-4.2%+11.3%+8.0%
YTD+16.5%+0.9%+15.6%+14.2%
1Y+16.1%+7.3%+8.8%+11.3%
3Y+64.9%+52.7%+12.1%+32.8%
5Y+69.9%+40.1%+29.8%+39.4%
All+295.6%+97.4%+198.2%+182.6%

Cumulative growth

Daily Returns

Daily percentage return beside GSK.

Daily Out/Under-Performance

Portfolio return minus GSK return. Positive bars indicate outperformance.

Daily Alpha

Portfolio daily return minus β × GSK return. Early observations use the first valid beta; later observations use the trailing beta estimated for each date.

Cumulative Out/Under-Performance

Relative wealth over 10y: compounded portfolio wealth divided by compounded GSK wealth, less one. Both series rebase at the selected span's start.

Cumulative Alpha

Compounded beta-adjusted residual returns apply the first valid beta to early observations, then the trailing beta ending on each date.

Updating return analytics…

10y analysis · Full analysis span regression · 6 months rolling